Table 2.
Baseline | Hazard ratio | 95% CI | P value |
---|---|---|---|
Age at diagnostic renal biopsy | 1.07 | 1.05−1.10 | <0.001 |
Male sex | 1.25 | 0.78−2.02 | 0.868 |
Race | |||
Caucasian | 1 | ||
African American | 1.15 | 0.36−3.66 | 0.056 |
Asian | 1.43 | 0.19−10.33 | 0.126 |
Diabetes | 2.22 | 0.79−6.17 | 0.126 |
Hypertension | 2.09 | 1.33−3.29 | 0.001 |
Chronic kidney disease stage at diagnosis | |||
1 (≥90 ml/min/1.73 m2) | 1 | ||
2 (60 < 90 ml/min/1.73 m2) | 1.97 | 0.87−4.48 | 0.103 |
3 (30 < 60 ml/min/1.73 m2) | 2.89 | 1.29−6.50 | 0.010 |
4 (15 < 30 ml/min/1.73 m2) | 9.18 | 4.17−20.23 | <0.001 |
5 (<15 ml/min/1.73 m2) | 10.19 | 4.41−23.57 | <0.001 |
Urine protein excretion (g/24 h) at diagnosis | |||
Mild <1 | 1 | ||
Moderate > 1 < 3 | 1.82 | 0.92−3.62 | 0.087 |
Severe >3 | 4.52 | 2.35−8.71 | <0.001 |
CI, confidence interval.
P values < 0.05 are considered to be significant.